Asselah, T., Chattergoon, M. A., Jucov, A., Streinu-Cercel, A., Lampertico, P., Wedemeyer, H., Kennedy, P. T., Gane, E. J., Bullard, B. L., Chow, S., Santos, D., Camus, G., Lu, Y., Pilowa, C., Hwang, C., Correll, T., Agarwal, K. (2026). A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2508827